TET1 and ovarian carcinoma: Therefore, we selected ES-2 cell line, derived from a CCC, for TET1-overexpression experiments, and demonstrated that this leads to an increase in 5hmC levels and the inhibition of ovarian cancer growth in vivo and in vitro.